Industry Payments and Branded Glatiramer Acetate Prescribing in the US Medicare Program | Neurology Clinical Practice
Background and ObjectivesGeneric formulations of glatiramer acetate have been available since 2015 yet remain underprescribed relative to the branded product. We sought to characterize the association between branded glatiramer prescribing in the Medicare …